Search Results - "van Laar, T."

Refine Results
  1. 1

    Deswelling and deformation of microgels in concentrated packings by Bouhid de Aguiar, I., van de Laar, T., Meireles, M., Bouchoux, A., Sprakel, J., Schroën, K.

    Published in Scientific reports (31-08-2017)
    “…Increasing the particle density of a suspension of microgel colloids above the point of random-close packing, must involve deformations of the particle to…”
    Get full text
    Journal Article
  2. 2

    A Method for Automatic and Objective Scoring of Bradykinesia Using Orientation Sensors and Classification Algorithms by Martinez-Manzanera, O., Roosma, E., Beudel, M., Borgemeester, R. W. K., van Laar, T., Maurits, N. M.

    “…Correct assessment of bradykinesia is a key element in the diagnosis and monitoring of Parkinson's disease. Its evaluation is based on a careful assessment of…”
    Get full text
    Journal Article
  3. 3

    Transition-state theory predicts clogging at the microscale by Laar, T. van de, Klooster, S. ten, Schroën, K., Sprakel, J.

    Published in Scientific reports (22-06-2016)
    “…Clogging is one of the main failure mechanisms encountered in industrial processes such as membrane filtration. Our understanding of the factors that govern…”
    Get full text
    Journal Article
  4. 4

    Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation by Siemeling, O, Slingerland, S, van der Zee, S, van Laar, T

    Published in BMC neurology (01-05-2024)
    “…To date, no disease modifying therapies are available for Parkinson's disease (PD). Since PD is the second most prevalent neurodegenerative disorder, there is…”
    Get full text
    Journal Article
  5. 5

    The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease by Bloem, B R, Marks, Jr, W J, Silva de Lima, A L, Kuijf, M L, van Laar, T, Jacobs, B P F, Verbeek, M M, Helmich, R C, van de Warrenburg, B P, Evers, L J W, intHout, J, van de Zande, T, Snyder, T M, Kapur, R, Meinders, M J

    Published in BMC neurology (17-07-2019)
    “…Our understanding of the etiology, pathophysiology, phenotypic diversity, and progression of Parkinson's disease has stagnated. Consequently, patients do not…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants by van Ogtrop, M L, van de Laar, T J W, Eggink, D, Vanhommerig, J W, van der Reijden, W A

    Published in Microbiology spectrum (22-12-2021)
    “…This study evaluates the performance of the PanBio COVID-19 antigen (Ag) test as part of a hospital infection control policy. Hospital staff was encouraged to…”
    Get full text
    Journal Article
  9. 9

    Lower Incidence of Parvovirus-B19 Infections in Dutch Blood Donors during SARS-CoV-2 Pandemic by Molenaar-de Backer, M W, Hogema, B M, Koppelman, M H, van de Laar, T J, Slot, E, Zaaijer, H L

    Published in Microbiology spectrum (31-10-2021)
    “…During the SARS-CoV-2 pandemic, several studies reported a lower incidence of respiratory infections other than COVID-19 compared to previous years, but bias…”
    Get full text
    Journal Article
  10. 10

    From cooperative to uncorrelated clogging in cross-flow microfluidic membranes by van Zwieten, R., van de Laar, T., Sprakel, J., Schroën, K.

    Published in Scientific reports (09-04-2018)
    “…The operational lifetime of filtration membranes is reduced by the clogging of pores and subsequent build-up of a fouling or cake layer. Designing membrane…”
    Get full text
    Journal Article
  11. 11

    The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α by Gort, E H, van Haaften, G, Verlaan, I, Groot, A J, Plasterk, R H A, Shvarts, A, Suijkerbuijk, K P M, van Laar, T, van der Wall, E, Raman, V, van Diest, P J, Tijsterman, M, Vooijs, M

    Published in Oncogene (06-03-2008)
    “…Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that play a crucial role in oxygen homeostasis. Intratumoral hypoxia and genetic…”
    Get full text
    Journal Article
  12. 12

    Radiation of parotid or submandibular glands is effective for drooling in patients with parkinsonism; a randomised double-blind placebo-controlled trial by Steenbakkers, R.J.H.M., van Doornik, S.P., Vissink, A., Kerdijk, W., van Laar, T.

    Published in Clinical parkinsonism & related disorders (01-01-2022)
    “…Drooling is a common symptom in patients with parkinsonism, causing physical and emotional distress. It is unknown which major salivary glands are the best…”
    Get full text
    Journal Article
  13. 13

    Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer by Suijkerbuijk, K.P.M., Fackler, M.J., Sukumar, S., van Gils, C.H., van Laar, T., van der Wall, E., Vooijs, M., van Diest, P.J.

    Published in Annals of oncology (01-11-2008)
    “…Promoter methylation is a common epigenetic mechanism to silence tumor suppressor genes during breast cancer development. We investigated whether…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Discontinuous nature of the repulsive-to-attractive colloidal glass transition by van de Laar, T., Higler, R., Schroën, K., Sprakel, J.

    Published in Scientific reports (04-03-2016)
    “…In purely repulsive colloidal systems a glass transition can be reached by increasing the particle volume fraction beyond a certain threshold. The resulting…”
    Get full text
    Journal Article
  16. 16

    From highly specialised to generally available modelling of shear induced particle migration for flow segregation based separation technology by Drijer, I., van de Laar, T., Vollebregt, H.M., Schroën, C.G.P.H.

    “…•Commercial CFD software (STAR-CCM+) is used to describe particle migration in flow.•Shear induced diffusion (SID) can be described by this accessible…”
    Get full text
    Journal Article
  17. 17

    Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study by Verschuur, Constant V M, Suwijn, S R, Post, B, Dijkgraaf, M, Bloem, B R, van Hilten, J J, van Laar, T, Tissingh, G, Deuschl, G, Lang, A E, de Haan, R J, de Bie, R M A

    Published in BMC neurology (19-11-2015)
    “…The aim of this study is to investigate if early treatment with levodopa has a beneficial disease modifying effect on Parkinson's disease (PD) symptoms and…”
    Get full text
    Journal Article
  18. 18

    Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries by Hamers, F P, Lankhorst, A J, van Laar, T J, Veldhuis, W B, Gispen, W H

    Published in Journal of neurotrauma (01-02-2001)
    “…Analysis of locomotion is an important tool in the study of peripheral and central nervous system damage. Most locomotor scoring systems in rodents are based…”
    Get more information
    Journal Article
  19. 19

    Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease by Verschuur, Constant V.M, Suwijn, Sven R, Boel, Judith A, Post, Bart, Bloem, Bas R, van Hilten, Johannes J, van Laar, Teus, Tissingh, Gerrit, Munts, Alexander G, Deuschl, Guenther, Lang, Anthony E, Dijkgraaf, Marcel G.W, de Haan, Rob J, de Bie, Rob M.A

    Published in The New England journal of medicine (24-01-2019)
    “…In a randomized, delayed-start trial of levodopa in Parkinson’s disease, with one group receiving the drug for 80 weeks and the other starting at 40 weeks, the…”
    Get full text
    Journal Article
  20. 20

    Hypoxia-inducible factor-1α expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas by GORT, E. H, GROOT, A. J, DERKS VAN DE VEN, T. L. P, VAN DER GROEP, P, VERLAAN, I, VAN LAAR, T, VAN DIEST, P. J, VAN DER WALL, E, SHVARTS, A

    Published in Oncogene (05-10-2006)
    “…Hypoxia-inducible factor-1 alpha (HIF-1α) is the regulatory subunit of the heterodimeric transcription factor HIF-1 and the key factor in cellular response to…”
    Get full text
    Journal Article